Pradeep Bompada

MOLECULAR BIOLOGIST · BIOINFORMATICIAN

Pradeep Bompada

I am a molecular biologist and bioinformatician whose research integrates molecular biology, functional genomics, genome editing, next-generation sequencing and computational biology to investigate gene regulation, chromatin biology and disease mechanisms.

📍 Aurora, Colorado, USA✉️ bompadap@gmail.com
Pradeep Bompada

ABOUT

Research at the intersection of biology and computation

I have developed a research profile that bridges wet-lab molecular biology and bioinformatics. My work spans CRISPR genome editing, next-generation sequencing, epigenetics, cancer biology, metabolism and computational analysis.

I am currently conducting research at the University of Colorado focused on pediatric brain tumors and regulatory mechanisms involving transcription, chromatin accessibility, single-cell genomics and three-dimensional genome organization.

12PubMed-indexed publications
10+Years of research experience
4Research institutions
Wet lab + DataIntegrated expertise

EDUCATION

Academic training

2021–2022

Data Science Coursework

Dalarna University, Sweden

Training in statistics, programming, machine learning foundations, computational analysis and data visualization.

2020

PhD in Molecular Biology

Lund University, Sweden

Research in epigenetic and transcriptomic regulation, pancreatic islet biology, type 2 diabetes and biomarker discovery.

2015

Master’s in Molecular Biology

Lund University, Sweden

Advanced training in molecular genetics, gene regulation, cell biology and experimental research.

2013

Bachelor’s in Biotechnology

GITAM University, India

Foundation in biotechnology, genetics, biochemistry, cell biology and molecular biology.

MAJOR RESEARCH THEMES

Areas of scientific investigation

These themes summarize the major biological questions, disease areas and analytical approaches that have shaped my research career.

Epigenetics and Gene Regulation

Investigating how chromatin modifications and transcriptional programs regulate cellular responses in health and disease.

  • Histone acetylation
  • Chromatin remodeling
  • Transcriptional regulation
  • ChIP-seq, ChIP-qPCR and RNA-seq

Type 2 Diabetes and Metabolism

Studying glucose-responsive gene regulation and molecular mechanisms controlling pancreatic β-cell function and diabetic complications.

  • TXNIP and hyperglycemia
  • Osteopontin regulation
  • Pancreatic islets
  • Diabetic kidney

Atherosclerosis and Macrophage Biology

Exploring lipid accumulation, ceramides and inflammatory macrophage responses in vascular disease.

  • Ceramide accumulation
  • Macrophage models
  • Patient-derived samples
  • Therapeutic-target identification

Cancer Biology

Investigating tumor-regulatory mechanisms and therapeutic vulnerabilities using experimental and computational genomics.

  • Pediatric brain tumors
  • Medulloblastoma
  • Glioma and DIPG
  • Ewing sarcoma

Pediatric Brain Tumors

Current research focuses on transcriptional and epigenetic mechanisms in childhood brain tumors.

  • DIPG and pediatric high-grade glioma
  • Medulloblastoma
  • CDK12-mediated transcription
  • Therapeutic resistance

Single-cell Genomics

Using high-resolution sequencing to characterize cellular heterogeneity, cell states and regulatory networks.

  • scRNA-seq
  • scATAC-seq
  • RNA+ATAC multiome
  • Trajectory and communication analysis

Bioinformatics

Developing reproducible workflows for large-scale sequencing data and publication-ready biological interpretation.

  • RNA-seq, ChIP-seq and ATAC-seq
  • Hi-C and 3D genome analysis
  • Differential analysis
  • R, Python and Linux

CRISPR Genome Engineering

Applying genome-editing approaches to functional genomics and disease-mechanism studies.

  • CRISPR/Cas9
  • Guide RNA design
  • Lentiviral delivery
  • Functional validation

PROFESSIONAL EXPERIENCE

Research stories across my career

November 2024–Present

University of Colorado Anschutz Medical Campus

Molecular Biology & Bioinformatics Research

My current research focuses on understanding the molecular mechanisms that drive pediatric brain tumors, including diffuse intrinsic pontine glioma, pediatric high-grade glioma and medulloblastoma. By integrating molecular biology with computational genomics, I investigate chromatin organization, transcriptional regulation and cellular heterogeneity using RNA sequencing, single-cell genomics, chromatin accessibility profiling and three-dimensional genome analyses. The goal is to identify mechanisms of tumor progression and therapeutic resistance that may contribute to improved treatment strategies.

Epigenetic regulationCDK12 biologyscRNA-seqscATAC-seqHi-CChromatin organizationTherapeutic resistance

June 2023–October 2024

City of Hope National Medical Center

Postdoctoral Research

During my postdoctoral research at City of Hope, I investigated molecular mechanisms regulating cancer progression using genome engineering, molecular biology and computational genomics. My work combined CRISPR/Cas9 genome editing, lentiviral vector systems, functional genomics, drug-response studies and analysis of public sequencing datasets to identify novel therapeutic targets and improve our understanding of cancer biology. This multidisciplinary approach integrated experimental validation with large-scale genomic analysis to support translational cancer research.

CRISPRLentiviral systemsFunctional genomicsEwing sarcomaDrug responsePublic NGS analysis

November 2022–May 2023

Lund University

Postdoctoral Research

My postdoctoral research investigated how lipid metabolism influences inflammation and cardiovascular disease. I focused on ceramide accumulation in macrophages and its contribution to atherosclerosis by combining molecular biology, cell culture and translational studies using patient-derived samples. This work aimed to identify molecular mechanisms that could support new therapeutic approaches for cardiovascular disease.

Ceramide biologyMacrophagesAtherosclerosisPatient samplesInflammation

Lund University

Doctoral Research

My doctoral research focused on understanding how epigenetic mechanisms regulate gene expression during metabolic disease. Using chromatin immunoprecipitation, RNA sequencing, molecular biology and bioinformatics analyses, I investigated histone acetylation, transcriptional regulation, pancreatic islet biology, diabetic kidney disease and blood-based biomarkers. This work contributed to a better understanding of the molecular pathways underlying type 2 diabetes and related metabolic disorders.

Histone acetylationTXNIPPancreatic isletsDiabetesChIP-seqRNA-seqBiomarkers

Assistant Researcher

Foundational Research Experience

My early research experience established the experimental foundation for my scientific career. During this period, I developed expertise in molecular biology techniques, laboratory organization, experimental design and collaborative biomedical research while gaining extensive hands-on experience in cell and molecular biology.

Cell culturePCRRT-qPCRELISAExperimental optimizationScientific documentation

TECHNICAL EXPERTISE

Methods and analytical platforms

Molecular Biology

Cell culturePrimary cellsPCRRT-qPCRChIPELISASDS-PAGE

Genome Editing

CRISPR/Cas9Guide RNA designLentivirusKnockoutsSNP editing

Sequencing Technologies

RNA-seqChIP-seqATAC-seqHi-CscRNA-seqscATAC-seqMultiome

Bioinformatics

SeuratScanpyHarmonyArchRCellChatTrajectory analysis

Programming

RPythonLinuxSnakemakeHPC

Scientific Communication

Publication figuresManuscriptsPresentationsMentoringCollaboration

CURRENT RESEARCH PROJECTS

University of Colorado

My current research focuses on understanding the molecular and epigenetic mechanisms underlying pediatric brain tumors through the integration of molecular biology, next-generation sequencing and computational genomics.

Epigenetic regulation in pediatric brain tumors

Investigating chromatin and transcriptional mechanisms that shape tumor-cell states and disease progression.

CDK12-mediated transcriptional regulation

Studying how CDK12 affects gene expression in glioma cells and identifying potential therapeutic strategies.

Single-cell transcriptomics

Resolving tumor-cell heterogeneity, immune states and cellular responses using scRNA-seq.

Single-cell chromatin accessibility

Characterizing regulatory elements and transcription-factor programs using scATAC-seq and multiome data.

Hi-C and 3D genome organization

Studying chromatin compartments, domain structure and long-range regulatory organization in brain tumor models.

Therapeutic resistance and tumor ecosystems

Integrating genomic layers to identify mechanisms of resistance and candidate therapeutic vulnerabilities.

PAST RESEARCH PROJECTS

Research programs across previous institutions

These projects summarize the scientific questions and experimental approaches that defined my earlier research at City of Hope and Lund University.

CITY OF HOPE NATIONAL MEDICAL CENTER

Postdoctoral Research

My postdoctoral research at City of Hope combined cancer biology, genome engineering and computational genomics to investigate mechanisms of tumor progression and identify potential therapeutic targets.

CRISPR-based functional genomics

Designed and applied CRISPR/Cas9 strategies to investigate candidate genes, generate edited cell models and evaluate their functional roles in cancer-related pathways.

Lentiviral vector production and delivery

Produced and titrated lentiviral vectors for efficient gene delivery, genome editing and downstream functional studies in mammalian cell systems.

Ewing sarcoma target discovery

Investigated genes and molecular pathways that influence Ewing sarcoma biology and the therapeutic response to candidate inhibitors.

Cancer drug-response studies

Performed drug titration and cell-based assays to characterize treatment responses and identify biologically relevant dose ranges.

Public NGS data mining

Analyzed publicly available sequencing datasets to identify candidate genes, regulatory mechanisms and therapeutic vulnerabilities for experimental follow-up.

Circadian gene regulation in adipogenesis

Investigated the role of a newly identified clock-related gene in adipocyte differentiation and metabolic regulation.

LUND UNIVERSITY

Postdoctoral Research

My postdoctoral work at Lund University focused on the relationship between lipid metabolism, macrophage biology and atherosclerotic disease using experimental models and patient-derived material.

Ceramide accumulation in macrophages

Developed in-vitro models to examine how ceramide accumulation changes macrophage function and contributes to disease-associated cellular states.

Macrophage inflammation and lipid metabolism

Studied the interaction between lipid handling, inflammatory signaling and macrophage biology in the context of vascular disease.

Atherosclerosis mechanisms

Investigated molecular and cellular processes that contribute to plaque development and progression in atherosclerotic disease.

Patient-derived sample studies

Handled and analyzed patient-derived samples to connect experimental observations with clinically relevant cardiovascular disease biology.

Therapeutic target exploration

Worked with clinical collaborators to evaluate molecular pathways that could represent potential intervention points in atherosclerosis.

Translational cardiovascular research

Integrated molecular experiments with clinically informed questions to improve understanding of lipid-driven vascular inflammation.

LUND UNIVERSITY

Doctoral Research

My doctoral research investigated how glucose and metabolic stress alter epigenetic regulation and gene expression in pancreatic islets, kidney tissue and blood cells.

Histone acetylation of TXNIP in pancreatic islets

Studied how glucose-induced histone acetylation regulates thioredoxin-interacting protein expression in pancreatic islets.

Epigenetic regulation of TXNIP in kidney

Investigated how hyperglycemia influences chromatin regulation and TXNIP expression in diabetic kidney tissue.

Osteopontin regulation in pancreatic islets

Examined the biological role of osteopontin and the molecular mechanisms controlling its expression in pancreatic islets.

Osteopontin regulation in diabetic kidney

Characterized glucose-stimulated epigenetic regulation of osteopontin expression in kidney-related diabetes models.

Epigenome-wide histone acetylation profiling

Analyzed histone acetylation changes in peripheral blood mononuclear cells from patients with type 2 diabetes and atherosclerotic disease.

Blood-based epigenetic biomarker discovery

Investigated disease-associated epigenetic signatures with potential relevance as blood-based biomarkers for metabolic disease.

ChIP-seq and RNA-seq method development

Developed cost-efficient chromatin immunoprecipitation and sequencing workflows for diverse cell and tissue systems.

Pancreatic islet transcriptomics

Integrated gene-expression profiling and bioinformatics to understand glucose-responsive transcriptional programs in pancreatic islets.

FOUNDATIONAL RESEARCH EXPERIENCE

Assistant Researcher

My early research experience established the experimental foundation for my later doctoral and postdoctoral work through hands-on molecular and cellular biology.

Mammalian cell culture

Maintained and experimentally manipulated mammalian cell models while developing strong aseptic technique and reproducible culture practices.

PCR and RT-qPCR workflows

Performed nucleic-acid extraction, primer-based amplification and quantitative gene-expression analysis for research projects.

Protein and functional assays

Applied SDS-PAGE, ELISA and related assays to evaluate molecular changes and cellular responses.

Experimental optimization

Improved laboratory protocols by comparing conditions, troubleshooting workflows and documenting reproducible procedures.

Scientific documentation

Maintained organized experimental records, summarized results and supported interpretation of collaborative research findings.

Laboratory organization

Supported project coordination, reagent planning and efficient execution of parallel experimental activities.

PUBLICATIONS

12 PubMed-indexed articles

Grouped by research area and listed with journal, authors, DOI and PMID.

Open complete PubMed search

Pediatric Brain Tumors

2025

Nature Communications

Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma.

Veo B, Wang D, DeSisto J, Pierce A, Brunt B, Bompada PC, Donson A, Goodspeed A, Smart K, Foreman N, Dahl N, Vibhakar R.

Nat Commun. 2025 Nov 25;16(1):10470.

PubMed DOI PMID: 41290646
2025

Neuro-Oncology

Targeting processive transcription for Myc-driven circuitry in medulloblastoma.

Sobral LM, Walker FM, Madhavan K, Janko E, Donthula S, Danis E, Bompada P, Balakrishnan I, Wang D, Pierce A, Haag MM, Carstens BJ, Serkova NJ, Foreman NK, Venkataraman S, Veo B, Vibhakar R, Dahl NA.

Neuro Oncol. 2025 Oct 1;27(10):2697-2710.

PubMed DOI PMID: 40372972

Diabetes & Epigenetics

2021

Biomedicines

Epigenome-Wide Histone Acetylation Changes in Peripheral Blood Mononuclear Cells in Patients with Type 2 Diabetes and Atherosclerotic Disease.

Bompada P, Goncalves I, Wu C, Gao R, Sun J, Mir BA, Luan C, Renström E, Groop L, Weng J, Hansson O, Edsfeldt A, De Marinis Y.

Biomedicines. 2021 Dec 14;9(12):1908.

PubMed DOI PMID: 34944721
2020

Diabetes, Obesity and Metabolism

Peptide YY (1-36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survival.

Lafferty RA, Tanday N, McCloskey A, Bompada P, De Marinis Y, Flatt PR, Irwin N.

Diabetes Obes Metab. 2020 Mar;22(3):404-416.

PubMed DOI PMID: 31692207
2019

Cell Metabolism

Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β Cells.

Zhang E, Mohammed Al-Amily I, Mohammed S, Luan C, Asplund O, Ahmed M, Ye Y, Ben-Hail D, Soni A, Vishnu N, Bompada P, De Marinis Y, Groop L, Shoshan-Barmatz V, Renström E, Wollheim CB, Salehi A.

Cell Metab. 2019 Jan 8;29(1):64-77.e6.

PubMed DOI PMID: 30293774
2018

Biochemical and Biophysical Research Communications

Role of osteopontin and its regulation in pancreatic islet.

Cai M, Bompada P, Salehi A, Acosta JR, Prasad RB, Atac D, Laakso M, Groop L, De Marinis Y.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):1426-1431.

PubMed DOI PMID: 29180017
2017

Obesity

Regulation of Nuclear Receptor Interacting Protein 1 (NRIP1) Gene Expression in Response to Weight Loss and Exercise in Humans.

De Marinis Y, Sun J, Bompada P, Domènech Omella J, Luan C, Halu A, Renström E, Sharma A, Ridderstråle M.

Obesity (Silver Spring). 2017 Aug;25(8):1400-1409.

PubMed DOI PMID: 28656645
2016

International Journal of Biochemistry & Cell Biology

Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets.

Bompada P, Atac D, Luan C, Andersson R, Omella JD, Laakso EO, Wright J, Groop L, De Marinis Y.

Int J Biochem Cell Biol. 2016 Dec;81(Pt A):82-91.

PubMed DOI PMID: 27989964
2016

Kidney International

Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney.

De Marinis Y, Cai M, Bompada P, Atac D, Kotova O, Johansson ME, Garcia-Vaz E, Gomez MF, Laakso M, Groop L.

Kidney Int. 2016 Feb;89(2):342-353.

PubMed DOI PMID: 26806835
2016

Biochemical and Biophysical Research Communications

Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney.

Cai M, Bompada P, Atac D, Laakso M, Groop L, De Marinis Y.

Biochem Biophys Res Commun. 2016 Jan 1;469(1):108-113.

PubMed DOI PMID: 26592666

Immunology

2019

Frontiers in Immunology

Interaction of Serum-Derived and Internalized C3 With DNA in Human B Cells-A Potential Involvement in Regulation of Gene Transcription.

Kremlitzka M, Nowacka AA, Mohlin FC, Bompada P, De Marinis Y, Blom AM.

Front Immunol. 2019 Mar 19;10:493.

PubMed DOI PMID: 30941132

COVID-19

2020

Infection Ecology & Epidemiology

Serology assessment of antibody response to SARS-CoV-2 in patients with COVID-19 by rapid IgM/IgG antibody test.

De Marinis Y, Sunnerhagen T, Bompada P, Bläckberg A, Yang R, Svensson J, Ekström O, Eriksson KF, Hansson O, Groop L, Gonçalves I, Rasmussen M.

Infect Ecol Epidemiol. 2020 Sep 20;10(1):1821513.

PubMed DOI PMID: 33062217

CURRICULUM VITAE

Academic and professional record

Download the complete CV for education, research experience, technical expertise and scientific contributions.

Download Curriculum Vitae

RESEARCH VISION

Integrating experimental and computational biology

My long-term goal is to integrate molecular biology, genomics and computational biology to understand disease mechanisms and translate genomic discoveries into meaningful biological insights. By combining experimental approaches with reproducible computational methods, I aim to contribute to more effective therapeutic strategies for complex human diseases.

CONTACT

Let’s connect and collaborate

Open to scientific collaborations, bioinformatics projects and research opportunities across molecular biology, cancer genomics and computational biology.

✉️ bompadap@gmail.com
📍 Aurora, Colorado, USA
🏛 University of Colorado Anschutz Medical Campus
📄 Download CV📚 PubMed publications